CD4+ T lymphocytes enhance tumor antigen-specific immune responses by producing cytokines, and CD8+ T cells provide key adaptive anti-tumor immunity through their production of IFN-γ and cytolytic activity [30]. This evidence concerns the gene CD8A and neoplasm.